Match!

Projections of cancer prevalence in the United Kingdom, 2010-2040.

Published on Sep 1, 2012in British Journal of Cancer5.416
· DOI :10.1038/bjc.2012.366
Jacob Maddams4
Estimated H-index: 4
,
Martin Utley29
Estimated H-index: 29
(UCL: University College London),
Henrik Møller68
Estimated H-index: 68
Abstract
BACKGROUND There are currently two million cancer survivors in the United Kingdom, and in recent years this number has grown by 3% per annum. The aim of this paper is to provide long-term projections of cancer prevalence in the United Kingdom. METHODS National cancer registry data for England were used to estimate cancer prevalence in the United Kingdom in 2009. Using a model of prevalence as a function of incidence, survival and population demographics, projections were made to 2040. Different scenarios of future incidence and survival, and their effects on cancer prevalence, were also considered. Colorectal, lung, prostate, female breast and all cancers combined (excluding non-melanoma skin cancer) were analysed separately. RESULTS Assuming that existing trends in incidence and survival continue, the number of cancer survivors in the United Kingdom is projected to increase by approximately one million per decade from 2010 to 2040. Particularly large increases are anticipated in the oldest age groups, and in the number of long-term survivors. By 2040, almost a quarter of people aged at least 65 will be cancer survivors. CONCLUSION Increasing cancer survival and the growing/ageing population of the United Kingdom mean that the population of survivors is likely to grow substantially in the coming decades, as are the related demands upon the health service. Plans must, therefore, be laid to ensure that the varied needs of cancer survivors can be met in the future.
  • References (15)
  • Citations (201)
📖 Papers frequently viewed together
187 Citations
320 Citations
35.5k Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References15
Newest
#1M Mistry (QMUL: Queen Mary University of London)H-Index: 1
#2D M Parkin (QMUL: Queen Mary University of London)H-Index: 13
Last. Peter Sasieni (QMUL: Queen Mary University of London)H-Index: 50
view all 4 authors...
Quantifying the future burden of cancer incidence and mortality, in terms of expected numbers of cases and deaths, or rates of disease, is important in optimising the allocation of resources for screening, diagnostic, therapeutic and palliative services and to provide a baseline from which the success of future interventions can be judged (Bray and Moller, 2006). The future number of cases (or deaths) is a consequence of two components of change; the evolution of the size and age structure of th...
169 CitationsSource
#1Jacob MaddamsH-Index: 4
#2Martin Utley (UCL: University College London)H-Index: 29
Last. Henrik MøllerH-Index: 68
view all 3 authors...
Cancer survivors are defined as people who are alive following a diagnosis of cancer from some point in their past. In UK, there are approximately 2 million cancer survivors (approximately 1.66 million of these in England), and this number is increasing by 3% per year (Maddams et al, 2009). The size and demographics of the population of cancer survivors has been described, but there is still a need for more detailed analyses of the burden of cancer on the individual and on health-service resourc...
12 CitationsSource
#1Michael J. RichardsH-Index: 32
#2Jessica Corner (University of Southampton)H-Index: 33
Last. J Maher (Macmillan Cancer Support)H-Index: 1
view all 3 authors...
The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors
80 CitationsSource
#1Jacob Maddams ('KCL': King's College London)H-Index: 4
#2Martin Utley (UCL: University College London)H-Index: 29
Last. Henrik Møller ('KCL': King's College London)H-Index: 68
view all 3 authors...
Abstract Background In the United Kingdom, there are approximately two million cancer survivors (3.2% of the entire population), composed of groups of people in different phases of survivorship and with different health service needs. The aim of this study was to quantify the level of acute health service utilisation by cancer survivors in the UK, according to tumour type, age, sex, time since diagnosis, and time until death. Methods Linked national cancer registry and hospital activity data wer...
22 CitationsSource
The United Kingdom has the highest age-standardized incidence of oesophageal cancer in Europe. This study projects the number of cases of oesophageal cancer arising in England over a 25-year period. Data from National Statistics were used to determine the number and incidence of oesophageal cancers diagnosed during 2001-2007 (separated by age and sex). These data were used with population projections to model the number of cancers that would develop in the future. Variant estimates were undertak...
9 CitationsSource
#1Francesca Fiorentino (UCL: University College London)H-Index: 17
#2Jacob Maddams ('KCL': King's College London)H-Index: 4
Last. Martin Utley (UCL: University College London)H-Index: 29
view all 4 authors...
Recent estimates suggest that there are 2 million people in the UK living with or beyond a diagnosis of cancer and there is increasing attention being given to assessing the health and social care needs of this growing population. A simple analytical model has been constructed to estimate future trends in cancer prevalence, using existing prevalence estimates and trends in cancer incidence and survival. Separate estimates are generated for the contribution to future prevalence due to the current...
3 CitationsSource
#1Jacob MaddamsH-Index: 4
#2David C. BrewsterH-Index: 67
Last. Henrik MøllerH-Index: 68
view all 7 authors...
187 CitationsSource
#1Nana Tabata (Osaka University)H-Index: 1
#2Yuko Ohno (Osaka University)H-Index: 18
Last. Akira OshimaH-Index: 9
view all 7 authors...
Measuring cancer prevalence in Japan has been difficult because population-based cancer registries have been conducted in limited areas. The purpose of this study was to estimate cancer prevalence in Japan from 1995 to 2020 for 5-year periods based on selected population-based cancer registry data. 1-, 2‐3-, 4‐5- and 5-year partial prevalence were estimated using incidence and survival data. Incidence and survival were calculated using data from selected cancer registries. We estimated the cance...
17 CitationsSource
#1Sirpa Heinävaara (UH: University of Helsinki)H-Index: 5
#2Timo HakulinenH-Index: 65
Incidence, survival, prevalence and mortality are the elements of the cancer burden. The cancer burden is thus contributed by the same individuals from the diagnosis of cancer (incidence) until possible death from cancer (mortality). It would therefore be natural that predictions of future cancer burden, those needed by health administration, for example, could be based on individual data. This paper presents a new model for estimating future cancer burden, a model where individuals are followed...
10 CitationsSource
25 Citations
Cited By201
Newest
#1Sarah Coleridge (NUH: Nottingham University Hospitals NHS Trust)
#2Jo MorrisonH-Index: 8
OBJECTIVE: Recurrence of low-risk endometrioid endometrial cancer is rare, and traditional hospital follow-up has a cost to both the patient and the healthcare system, without evidence of benefit. We examined the uptake of patient-initiated follow-up, pattern of recurrences, and survival for women following surgical treatment of low-risk endometrial cancer and compared estimated costs with hospital follow-up. METHODS: This study was a prospective audit of outcomes following implementation of a p...
Source
#1R. Balasubramaniam (Royal College of Radiologists)
#2K. Drinkwater (Royal College of Radiologists)H-Index: 7
Last. D.C. Howlett (Royal College of Radiologists)
view all 3 authors...
Aim A national audit reviewing compliance of imaging departments with the Royal College of Radiologist (RCR) standards for cancer multidisciplinary team meetings (MDTMs). Materials and methods The audit consisted of a generic and subspecialty component completed for breast, colorectal, and lung cancer MDTMs. Results The study achieved the highest response from a RCR national audit with 145/191 (76%) hospitals responding. Compliance with the RCR standards was suboptimal, particularly relating to ...
Source
#1R. Morris (NUH: Nottingham University Hospitals NHS Trust)
#2A. Lewis (NUH: Nottingham University Hospitals NHS Trust)
Abstract Falls among older people are common and are associated with substantial morbidity, mortality and healthcare costs. Increasingly cancer is becoming a disease of older people and fall rates are higher in elders living with cancer. Cancer and its treatments potentiate important risk factors for falls, including muscle weakness, poor balance, proprioception, cognitive impairment and functional disability. Sarcopenia refers to the progressive deterioration in muscle strength, mass and qualit...
Source
#1Yimin ChaoH-Index: 19
Last. Yongping BaoH-Index: 32
view all 8 authors...
The functionalisation of silicon nanoparticles with a terminal thiocyanate group, producing isothiocyanate-capped silicon nanoparticles (ITC-capped SiNPs) has been successfully attained. The procedure for synthesis is a two-step process that occurs via thermally induced hydrosilylation of hydrogen terminated silicon nanoparticle (H-SiNPs) and further reaction with potassium thiocyanate (KSCN). The synthesis was confirmed by Fourier Transform Infrared (FTIR) spectroscopy and X-Ray Photoelectron S...
Source
Source
#1Nalinie Joharatnam-Hogan (UCL: University College London)H-Index: 1
#2Kai Keen Shiu (UCL: University College London)
Last. Khurum Khan (UCL: University College London)
view all 3 authors...
Abstract Gastric cancer is considered an age-related disease, with the majority of new cases in the UK diagnosed in individuals over the age of 75. At present most guidance related to the management of gastric cancer is based on trials undertaken in the fit, younger patient. Historically the elderly have been underrepresented in clinical trials, which frequently have a restricted inclusion to an upper age limit of 75. The European Society for Medical Oncology (ESMO) recommends use of a geriatric...
Source
#1Kinta Beaver (UCLan: University of Central Lancashire)H-Index: 29
#2Pierre L. Martin-Hirsch (Lancashire Teaching Hospitals NHS Foundation Trust)H-Index: 29
Last. Maria Kyrgiou (Imperial College Healthcare)H-Index: 1
view all 4 authors...
Abstract Purpose There is a strong shift away from hospital-based approaches to follow-up after active treatment for cancer with supported self-management being promoted as an approach to long term recovery. We aimed to determine the acceptability and feasibility of patient-initiated follow-up (PIFU), supported by a self-management approach, for patients treated for Stage I endometrial cancer. Methods A mixed methods study was undertaken. Participants were asked to forego hospital outpatient fol...
2 CitationsSource
#1Kinta Beaver (UCLan: University of Central Lancashire)H-Index: 29
#2Susan Williamson (UCLan: University of Central Lancashire)H-Index: 9
Last. Pierre L. Martin-Hirsch (Lancashire Teaching Hospitals NHS Foundation Trust)H-Index: 29
view all 5 authors...
Abstract Purpose Alternatives to hospital follow-up (HFU) following treatment for cancer have been advocated. Telephone follow-up (TFU) and patient-initiated follow-up are being implemented but it is unclear if these approaches will meet the preferences and needs of patients. This study aimed to explore the preferences of endometrial cancer patients and their levels of satisfaction with HFU and nurse-led TFU. Methods A cross-sectional survey design was utilised and a questionnaire was administer...
1 CitationsSource
#1Anita FellerH-Index: 5
Last. Sabine RohrmannH-Index: 62
view all 13 authors...
BACKGROUND: More people than ever before are currently living with a diagnosis of cancer and the number of people concerned is likely to continue to rise. Cancer survivors are at risk of developing a second primary cancer (SPC). This study aims to investigate the risk of SPC in Switzerland. METHODS: The study cohort included all patients with a first primary cancer recorded in 9 Swiss population-based cancer registries 1981-2009 who had a minimum survival of 6 months, and a potential follow-up u...
2 CitationsSource
#2Candida S. McCabeH-Index: 9
Last. Alison. LlewellynH-Index: 2
view all 5 authors...
Introduction There have been significant improvements in cancer survival in recent decades but not everyone is living well. Nearly 40% of cancer survivors have chronic pain, however, little is known about their experiences (1). Those with chronic pain may be cared for across specialities, including primary care, secondary care and specialist pain clinics (2). To enable continuity of care across specialties, and to improve services, it is important to understand the experiences chronic pain in ca...